APGE
Apogee Therapeutics, Inc. Common Stock
NASDAQ: APGE · HEALTHCARE · BIOTECHNOLOGY
$82.03
-3.91% today
Updated 2026-04-29
Market cap
$6.39B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.22
Dividend yield
—
52W range
$34 – $95
Volume
0.9M
Apogee Therapeutics, Inc. Common Stock (APGE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-31.60%
ROA
-21.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-39.78M | — | — | — |
| 2023 | $0.00 | $-83.98M | — | — | — |
| 2024 | $0.00 | $-182.15M | — | — | — |
| 2025 | $0.00 | $-255.84M | — | — | — |